|
市場調査レポート
商品コード
1730127
咳・風邪・アレルギー：パンデミック後の世界におけるCCAの機会の解明Cough, Cold & Allergy: Unravelling CCA Opportunities in a Post-Pandemic World |
||||||
|
|||||||
| 咳・風邪・アレルギー：パンデミック後の世界におけるCCAの機会の解明 |
|
出版日: 2025年07月31日
発行: Nicholas Hall Group of Companies
ページ情報: 英文
納期: 即納可能
 |
- 全表示
- 概要
- 目次
咳・風邪・アレルギーは、2024年に世界でもっとも成長が鈍化したCHCカテゴリです。多くの製品の需要は季節性疾患の罹患率や重症度に左右されますが、マーケティング担当者は、大気汚染レベルの高さなど、通年売上を促進する新たなニッチを特定しつつあります。さまざまな成分の規制が続く中、「自然派」志向がNPD活動を後押ししていますが、消費者は複数の症状に対応し、即効性のある「オールインワン」製品も求めています。アレルギー治療薬は、スイッチ活動が今後も成長とイノベーションの有力な要因であり続けるため、よりよい成長が見込まれます。免疫関連製品に対する需要が（咳・風邪ブランドやサプリメントの間で）冷え込む中、マーケティング担当者は新たなニッチを見つける必要に迫られる可能性があります。
当レポートでは、世界の咳・風邪・アレルギー市場について調査分析し、国別、カテゴリ別の売上データや、各ブランドの業績、2029年と2034年までの予測などの情報を提供しています。
詳細に取り上げる10の個別市場
|
|
|
簡略に取り上げる追加の市場
|
|
|
|
目次
エグゼクティブサマリー
米国
- 概要
- 咳止め薬
- 全身性の風邪・インフルエンザ
- 全身性充血除去薬
- 局所充血除去薬
- 胸部擦過・吸入薬
- 喉の痛みの治療薬・薬用菓子
- アレルギー治療薬
- 喘息治療薬
- インターネット・通信販売チャネル
- 免疫関連VMS
- 見通し、予測、機会
中国
- 概要
- 咳止め薬
- 全身性の風邪・インフルエンザ
- 全身性充血除去薬
- 局所充血除去薬
- 胸部擦過・吸入薬
- 喉の痛みの治療薬・薬用菓子
- アレルギー治療薬
- 喘息治療薬
- インターネット・通信販売チャネル
- 免疫関連VMS
- 見通し、予測、機会
ドイツ
- 概要
- 咳止め薬
- 全身性の風邪・インフルエンザ
- 全身性充血除去薬
- 局所充血除去薬
- 胸部擦過・吸入薬
- 喉の痛みの治療薬・薬用菓子
- アレルギー治療薬
- インターネット・通信販売チャネル
- 免疫関連VMS
- 見通し、予測、機会
日本
- 概要
- 咳止め薬
- 全身性の風邪・インフルエンザ
- 局所充血除去薬
- 喉の痛みの治療薬・薬用菓子
- アレルギー治療薬
- インターネット・通信販売チャネル
- 見通し、予測、機会
イタリア
- 概要
- 咳止め薬
- 全身性の風邪・インフルエンザ
- 全身性充血除去薬
- 局所充血除去薬
- 喉の痛みの治療薬・薬用菓子
- アレルギー治療薬
- 免疫関連VMS
- 見通し、予測、機会
インド
- 概要
- 咳止め薬
- 全身性の風邪・インフルエンザ
- 局所充血除去薬
- 胸部擦過・吸入薬
- 喉の痛みの治療薬・薬用菓子
- アレルギー治療薬
- インターネット・通信販売チャネル
- 免疫関連VMS
- 見通し、予測、機会
ポーランド
- 概要
- 咳止め薬
- 全身性の風邪・インフルエンザ
- 全身性充血除去薬
- 局所充血除去薬
- 喉の痛みの治療薬・薬用菓子
- アレルギー治療薬
- インターネット・通信販売チャネル
- 免疫関連VMS
- 見通し、予測、機会
ブラジル
- 概要
- 咳止め薬
- 全身性の風邪・インフルエンザ
- 全身性充血除去薬
- 局所充血除去薬
- 胸部擦過・吸入薬
- 喉の痛みの治療薬・薬用菓子
- アレルギー治療薬
- インターネット・通信販売チャネル
- 免疫関連VMS
- 見通し、予測、機会
フランス
- 概要
- 咳止め薬
- 全身性の風邪・インフルエンザ
- 局所充血除去薬
- 胸部擦過・吸入薬
- 喉の痛みの治療薬・薬用菓子
- アレルギー治療薬
- インターネット・通信販売チャネル
- 免疫関連VMS
- 見通し、予測、機会
英国
- 概要
- 咳止め薬
- 全身性の風邪・インフルエンザ
- 全身性充血除去薬
- 局所充血除去薬
- 胸部擦過・吸入薬
- 喉の痛みの治療薬・薬用菓子
- アレルギー治療薬
- 免疫関連VMS
- 見通し、予測、機会
その他の市場
- オーストラリア
- カナダ
- メキシコ
- ロシア
見通し
- 短期予測と機会
- 長期予測と機会
Key features of the report:
- An in-depth exploration of the CHC Cough, Cold & Allergy market globally, including Cough remedies, Systemic cold & flu, Allergy remedies, Decongestants, Sore throat remedies and more
- Immunity-related VMS - including vitamin C, zinc and immune supplements - also investigated
- Very latest year-end 2024 sales from the just-published DB6, our dedicated CHC sales database, plus historical growth rates back to 2020
- Internet & mail order channel sales for every market profiled
- Coverage of marketer activity, highlighting strategies and success factors, sales, NPD activity and consumer & HCP promotion
- Coverage of 14 major markets from around the world, with topline sales, brand performances, latest developments, launches and promotional campaigns
- A look to the future includes long-term forecast sales for all categories and countries to 2029 & 2034, plus the most up-to-date short-term forecasts (to 2025 & 2026)
Cough, Cold & Allergy was the slowest-growing CHC category globally in 2024, as systemic cold & flu and cough remedies progressed at a modest rate, but the outlook is steady, with growth trends returning to a more normal level. While demand for many products is dependent on incidence and severity of seasonal pathologies, marketers are identifying new niches to drive year-round sales such as high levels of air pollution. As restrictions continue on various ingredients, the trend towards "naturals" has fuelled NPD activity, but consumers are also demanding multi-symptom, fast-acting or "all-in-one" products. Allergy remedies look set for better growth, as switch activity remains a robust influencer of growth and innovation in the future. As demand for immunity-related products cools (among cough & cold brands and supplements), marketers may need to find new niches.
This report will investigate pressing issues affecting the global CCA market, digging into multiple areas of interest and highlighting inherent opportunities. Examining ten core markets in detail (and additional key markets in brief), analysing brand performances and launch activity, our CCA report will investigate the untapped potential in this CHC category.
The report features the latest end-2024 sales data from our dedicated DB6 database, including topline historical sales globally, by country and category, as well as individual brand performances, and long-term forecasts to 2029 and 2034. Coverage extends to the online channel, with internet & mail order sales of CCA included in the topline and a dedicated section in each country profile.
Diving into the factors affecting individual Cough, Cold & Allergy markets, from consumer trends and regulatory changes to A+P campaigns and new product launch activity, this report sheds light on trends & developments across 10 in-depth country profiles with insights and predictions, as well as shorter profiles of other key markets.
Categories covered in this report include:
- Cough remedies
- Systemic cold & flu
- Systemic decongestants
- Topical decongestants
- Chest rubs & inhalants
- Sore throat remedies & medicated confectionery
- Allergy remedies
- Asthma remedies 1
- Immunity-related supplements 2
"1" selected markets only.
"2" sales tracked under VMS in DB6 (vitamin C, zinc, immune supplements).
Assessing the short-term outlook, the report includes full year 2025 & 2026 forecasts for all categories in each market profiled.
With launch activity in CCA picking up again after several years of decline, has the impetus shifted from quantity to quality? New product development is explored across markets, including Rx-to-OTC switches, delivery format innovations, new benefits and more.
Key questions investigated in this report:
- How do key growth drivers, consumer choices and competitive landscape differ from market to market?
- Which marketers and brands have proved most successful?
- Has NPD benefited the CCA market and can it be a future growth driver?
- What are the opportunities for e-commerce and digital marketing for CCA brands?
- Can new niches and underserved demographics be identified?
- How is the adjacent category of immunity-related supplements faring?
- What is the outlook for CCA and where can opportunities be found?
10 individual markets profiled in depth:
|
|
|
Plus additional markets in brief:
|
|
|
|
Table of Contents
Executive Summary
- Global CCA snapshot
- Category review
- Outlook, forecasts & opportunities
USA
- Overview
- Cough remedies
- Systemic cold & flu
- Systemic decongestants
- Topical decongestants
- Chest rubs & inhalants
- Sore throat remedies & medicated confectionery
- Allergy remedies
- Asthma remedies
- Internet & mail order channel
- Immunity-related VMS
- Outlook, forecasts & opportunities
China
- Overview
- Cough remedies
- Systemic cold & flu
- Systemic decongestants
- Topical decongestants
- Chest rubs & inhalants
- Sore throat remedies & medicated confectionery
- Allergy remedies
- Asthma remedies
- Internet & mail order channel
- Immunity-related VMS
- Outlook, forecasts & opportunities
Germany
- Overview
- Cough remedies
- Systemic cold & flu
- Systemic decongestants
- Topical decongestants
- Chest rubs & inhalants
- Sore throat remedies & medicated confectionery
- Allergy remedies
- Internet & mail order channel
- Immunity-related VMS
- Outlook, forecasts & opportunities
Japan
- Overview
- Cough remedies
- Systemic cold & flu
- Topical decongestants
- Sore throat remedies & medicated confectionery
- Allergy remedies
- Internet & mail order channel
- Outlook, forecasts & opportunities
Italy
- Overview
- Cough remedies
- Systemic cold & flu
- Systemic decongestants
- Topical decongestants
- Sore throat remedies & medicated confectionery
- Allergy remedies
- Immunity-related VMS
- Outlook, forecasts & opportunities
India
- Overview
- Cough remedies
- Systemic cold & flu
- Topical decongestants
- Chest rubs & inhalants
- Sore throat remedies & medicated confectionery
- Allergy remedies
- Internet & mail order channel
- Immunity-related VMS
- Outlook, forecasts & opportunities
Poland
- Overview
- Cough remedies
- Systemic cold & flu
- Systemic decongestants
- Topical decongestants
- Sore throat remedies & medicated confectionery
- Allergy remedies
- Internet & mail order channel
- Immunity-related VMS
- Outlook, forecasts & opportunities
Brazil
- Overview
- Cough remedies
- Systemic cold & flu
- Systemic decongestants
- Topical decongestants
- Chest rubs & inhalants
- Sore throat remedies & medicated confectionery
- Allergy remedies
- Internet & mail order channel
- Immunity-related VMS
- Outlook, forecasts & opportunities
France
- Overview
- Cough remedies
- Systemic cold & flu
- Topical decongestants
- Chest rubs & inhalants
- Sore throat remedies & medicated confectionery
- Allergy remedies
- Internet & mail order channel
- Immunity-related VMS
- Outlook, forecasts & opportunities
UK
- Overview
- Cough remedies
- Systemic cold & flu
- Systemic decongestants
- Topical decongestants
- Chest rubs & inhalants
- Sore throat remedies & medicated confectionery
- Allergy remedies
- Immunity-related VMS
- Outlook, forecasts & opportunities
Additional Markets
- Australia
- Canada
- Mexico
- Russia
Outlook
- Short-term forecasts & opportunities
- Long-term forecasts & opportunities
